Yestar Healthcare : INSIDE INFORMATION POSSIBLE ACQUISITION

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Yestar Healthcare Holdings Company Limited

巨 星 醫 療 控 股 有 限 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2393)

INSIDE INFORMATION

POSSIBLE ACQUISITION

This announcement is made by Yestar Healthcare Holdings Company Limited (the ''Company'') pursuant to Rule 13.09(2) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the ''Listing Rules'') and the Inside Information Provisions (as defined under the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

THE POSSIBLE ACQUISITION

The board of directors of the Company hereby announces that the Company is in the process of considering and discussing the feasibility of an acquisition (the ''Possible Acquisition'') of all the remaining interests in one of the non-wholly-owned subsidiaries of the Company.

Taking into account the recent weak sentiment of medical healthcare industry in the People's Republic of China (the ''PRC''), the Company intends to further expand and consolidate its market share in the PRC. As at the date of this announcement, no definitive legally binding agreement or contract has been entered into by the Company. The Possible Acquisition is subject to further negotiation between parties, which may or may not materialize. If materialize, the Possible Acquisition is expected to constitute a notifiable transaction of the Company under Chapter 14 of the Listing Rules.

Shareholders of the Company and potential investors should note that the Possible Acquisition may or may not materialize. Shareholders of the Company and the potential investors are urged to exercise caution when dealing in the securities of the Company.

- 1 -

Further detailed announcement(s) will be made by the Company in compliance with the requirements of the Listing Rules as and when appropriate, when there is any material development in connection with the Possible Acquisition.

By Order of the Board

Yestar Healthcare Holdings Company Limited

巨星醫療控股有限公司

Hartono James

Chairman, CEO and Executive Director

Shanghai, 3 August 2020

As at the date of this announcement, the executive Directors are Mr. Hartono James, Ms. Wang Ying, Ms. Wang Hong and Mr. Chan Chung Man; the independent non-executive Directors are Dr. Hu Yiming, Mr. Karsono Tirtamarta (Kwee Yoe Chiang) and Mr. Sutikno Liky.

In case of any inconsistency, the English text of this announcement shall prevail over the Chinese text.

- 2 -